Literature DB >> 15014055

Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature.

Mark H Ebell1, Jay Siwek, Barry D Weiss, Steven H Woolf, Jeffrey Susman, Bernard Ewigman, Marjorie Bowman.   

Abstract

A large number of taxonomies are used to rate the quality of an individual study and the strength of a recommendation based on a body of evidence. We have developed a new grading scale that will be used by several family medicine and primary care journals (required or optional), with the goal of allowing readers to learn one taxonomy that will apply to many sources of evidence. Our scale is called the Strength of Recommendation Taxonomy. It addresses the quality, quantity, and consistency of evidence and allows authors to rate individual studies or bodies of evidence. The taxonomy is built around the information mastery framework, which emphasizes the use of patient-oriented outcomes that measure changes in morbidity or mortality. An A-level recommendation is based on consistent and good quality patient-oriented evidence; a B-level recommendation is based on inconsistent or limited quality patient-oriented evidence; and a C-level recommendation is based on consensus, usual practice, opinion, disease-oriented evidence, or case series for studies of diagnosis, treatment, prevention, or screening. Levels of evidence from 1 to 3 for individual studies also are defined. We hope that consistent use of this taxonomy will improve the ability of authors and readers to communicate about the translation of research into practice.

Entities:  

Mesh:

Year:  2004        PMID: 15014055     DOI: 10.3122/jabfm.17.1.59

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  98 in total

1.  Is There Less Opioid Abuse in States Where Marijuana Has Been Decriminalized, Either for Medicinal or Recreational Use? A Clin-IQ.

Authors:  Aaron M Wendelboe; Richard Mathew; Tana Chongsuwat; Elizabeth Rainwater; Mark A Wendelboe; Elizabeth Wickersham; Ann F Chou
Journal:  J Patient Cent Res Rev       Date:  2019-10-28

2.  Automatically identifying health outcome information in MEDLINE records.

Authors:  Dina Demner-Fushman; Barbara Few; Susan E Hauser; George Thoma
Journal:  J Am Med Inform Assoc       Date:  2005-10-12       Impact factor: 4.497

Review 3.  Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology.

Authors:  Piergiorgio Neri; Manuela Zucchi; Pia Allegri; Marta Lettieri; Cesare Mariotti; Alfonso Giovannini
Journal:  Int Ophthalmol       Date:  2011-02-02       Impact factor: 2.031

Review 4.  Factors influencing death at home in terminally ill patients with cancer: systematic review.

Authors:  Barbara Gomes; Irene J Higginson
Journal:  BMJ       Date:  2006-02-08

Review 5.  A systematic review of prophylactic braces in the prevention of knee ligament injuries in collegiate football players.

Authors:  Brian G Pietrosimone; Terry L Grindstaff; Shelley W Linens; Elizabeth Uczekaj; Jay Hertel
Journal:  J Athl Train       Date:  2008 Jul-Aug       Impact factor: 2.860

Review 6.  Systematic review of postural control and lateral ankle instability, part I: can deficits be detected with instrumented testing.

Authors:  Patrick O McKeon; Jay Hertel
Journal:  J Athl Train       Date:  2008 May-Jun       Impact factor: 2.860

Review 7.  Dosage effects of neuromuscular training intervention to reduce anterior cruciate ligament injuries in female athletes: meta- and sub-group analyses.

Authors:  Dai Sugimoto; Gregory D Myer; Kim D Barber Foss; Timothy E Hewett
Journal:  Sports Med       Date:  2014-04       Impact factor: 11.136

Review 8.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

9.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Timothy G Berger; Alfons Krol; Amy S Paller; Kathryn Schwarzenberger; James N Bergman; Sarah L Chamlin; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; David J Margolis; Robert A Silverman; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527

10.  Using disablement models and clinical outcomes assessment to enable evidence-based athletic training practice, part II: clinical outcomes assessment.

Authors:  Tamara C Valovich McLeod; Alison R Snyder; John T Parsons; R Curtis Bay; Lori A Michener; Eric L Sauers
Journal:  J Athl Train       Date:  2008 Jul-Aug       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.